We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

The Neuroscience of Psychedelics – Harnessing Neuroplasticity for New Therapeutics

The Neuroscience of Psychedelics – Harnessing Neuroplasticity for New Therapeutics

In recent years, there has been a resurgence of interest in the potential therapeutic benefits of psychedelic substances. This webinar will explore the intersection of neuroscience and psychedelics, highlighting their potential therapeutic benefits for mental health conditions such as depression, anxiety, PTSD, and addiction.

Dr. Reichelt will delve into the neurobiology of psychedelics, emphasizing their role in promoting neuroplasticity, which allows for the rewiring of the brain. Ongoing clinical research will also be discussed, including the use of these substances in controlled settings to address trauma, reduce symptoms, and tackle substance dependence. Finally, Dr. Reichelt will explore next-generation psychedelics without hallucinatory effects and the potential of psychedelics as innovative therapeutic tools in psychiatry and neurology.

Speaker
Amy Reichelt, PhD
Amy Reichelt, PhD
Chief Innovation Officer
PurMinds Neuropharma
Now Available on Demand!
Want to invite a colleague?

Click the button below to begin inviting a colleague to this Webinar